Plain-English translation of NCT05582772 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This is a pilot study testing two supportive care approaches โ or a combination of both โ for men age 65 and older who have advanced prostate cancer and are starting or switching hormone therapy treatments called ARATs. One approach includes a thorough health assessment with a geriatrician (a doctor who specializes in older adults), and the other involves checking in weekly via email about how you're feeling. The study wants to see if these programs help people stay on their treatment longer, feel better, and experience fewer side effects.
Older men with advanced prostate cancer often struggle with side effects and complications while on hormone therapy, and doctors don't yet have a proven way to support them through this. This study is testing whether personalized health monitoring and early problem-solving can help people tolerate the treatment better and live better during their care.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You will be randomly assigned to one of four groups: a detailed health assessment with follow-up phone calls from a nurse, weekly symptom check-ins by email, both approaches combined, or usual care (no extra support). If you receive the health assessment, a trained nurse and geriatrician will review eight areas of your health โ like medication, nutrition, falls risk, and mood โ and create a plan to address any problems. Follow-up calls will happen at 1, 3, and 6 months. If you're in the symptom monitoring group, you'll complete brief weekly surveys about how you're feeling. The study lasts about 6 months of active participation.
AI-generated summary from trial data ยท Jul 15, 2026 ยท Not medical advice
Canada